AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32349879 — intervention group
Group type: COMPARATOR
Intervention: Meropenem followed by colistin + high-dose meropenem
Number of subjects: 0
Study 33555941 — intervention group
Group type: EXPERIMENTAL
Intervention: R2CHOP
Number of subjects: 280
Study 33555941 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 280
Study 32482455 — intervention group
Group type: EXPERIMENTAL
Intervention: EX‐MEAL (exercise + lunch)
Number of subjects: 17
Study 32482455 — intervention group
Group type: EXPERIMENTAL
Intervention: MEAL‐EX (lunch + exercise)
Number of subjects: 17
Study 32482455 — intervention group
Group type: COMPARATOR
Intervention: CON (rest + lunch)
Number of subjects: 17
Study 35956366 — intervention group
Group type: COMPARATOR
Intervention: WB + whole kiwifruit pulp (WB+KF)
Number of subjects: 9
Study 35956366 — intervention group
Group type: EXPERIMENTAL
Intervention: WB + neutralised kiwifruit pulp (WB+KFneut)
Number of subjects: 9
Study 35956366 — intervention group
Group type: EXPERIMENTAL
Intervention: WB + low‐fibre kiwifruit juice (WB+KFjuice)
Number of subjects: 9
Study 35956366 — intervention group
Group type: EXPERIMENTAL
Intervention: WB + KFsug + kiwifruit organic acids (WB+KFsug+OA)
Number of subjects: 9
Study 33527721 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/d Alpha Lipoic Acid (ALA)
Number of subjects: 26
Study 33527721 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn starch)
Number of subjects: 26
Study 32698855 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed drainage
Number of subjects: 420
Study 32698855 — intervention group
Group type: COMPARATOR
Intervention: Non-drainage
Number of subjects: 420
Study 34989288 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced consent procedures (ECPs)
Number of subjects: 40
Study 34989288 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 33647676 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 110
Study 33257420 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 91356
Study 33257420 — intervention group
Group type: COMPARATOR
Intervention: Non-use of Metformin
Number of subjects: 91356
Study 35840293 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based AF screening using a handheld single-lead ECG recorder and a smartphone application.
Number of subjects: 0
Study 35840293 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without home-based AF screening).
Number of subjects: 0
Study 32493290 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot MTA (MTA)
Number of subjects: 50
Study 32493290 — intervention group
Group type: EXPERIMENTAL
Intervention: RetroMTA (RMTA)
Number of subjects: 50
Study 32493290 — intervention group
Group type: EXPERIMENTAL
Intervention: RetroMTA + DBA (RMTA-B)
Number of subjects: 50
Study 32493290 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot + DBA (MTA-B)
Number of subjects: 50
Study 32493290 — intervention group
Group type: COMPARATOR
Intervention: Control group (composite resin only)
Number of subjects: 50
Study 36048793 — intervention group
Group type: EXPERIMENTAL
Intervention: STRETCH
Number of subjects: 21
Study 36048793 — intervention group
Group type: COMPARATOR
Intervention: TRAD
Number of subjects: 21
Study 34789234 — intervention group
Group type: EXPERIMENTAL
Intervention: Watch Me Grow‐ Electronic (WMG‐E) intervention group with continuity of care and additional in‐person assessment by a service navigator.
Number of subjects: 300
Study 34789234 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual group receiving electronic direction to relevant resources.
Number of subjects: 300
Study 32568447 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Move It intervention
Number of subjects: 21
Study 36133316 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial L‐T4 dose of 10‐12.5 μg/kg/day (Low)
Number of subjects: 45
Study 36133316 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial L‐T4 dose of 12.6‐15 μg/kg/day (High)
Number of subjects: 45
Study 36133316 — intervention group
Group type: COMPARATOR
Intervention: Both treatment schemes (Low and High)
Number of subjects: 45
Study 33624275 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Tranexamic Acid (TXA) administered as 1 gram bolus and 1 gram every 6 hours for 48 hours
Number of subjects: 94
Study 33624275 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered in the same way as TXA
Number of subjects: 94
Study 35180779 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral sleep treatment
Number of subjects: 30
Study 35180779 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual attention-controlled comparison group
Number of subjects: 30
Study 33691506 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily steps at 2 months poststroke (≥1632 daily steps)
Number of subjects: 206
Study 33691506 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily steps at 2 months and balance (Berg Balance Scale score)
Number of subjects: 206
Study 32792614 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 hours of normobaric hypoxia (3,000 m)
Number of subjects: 40
Study 32792614 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 hour of normobaric hypoxia (3,000 m)
Number of subjects: 40
Study 32792614 — intervention group
Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 40
Study 34623205 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exposure exercise
Number of subjects: 99
Study 34623205 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 99
Study 34260986 — intervention group
Group type: EXPERIMENTAL
Intervention: Home‐based multimodal exercise program (AD‐HOMEX), 16 weeks, 3 sessions per week, 60 minutes each session
Number of subjects: 40
Study 34260986 — intervention group
Group type: EXPERIMENTAL
Intervention: Home‐based multimodal exercise program (AD‐HOMEX)
Number of subjects: 40
Study 34260986 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study 35578345 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of the Clinical Decision Support System (CDSS) for hypertension management
Number of subjects: 94
Study 35578345 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 94
Study 35578345 — intervention group
Group type: EXPERIMENTAL
Intervention: Different initial mono- or dual-antihypertensive therapy (nested trial LIGHT-ACD)
Number of subjects: 94
Study 33660924 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (0.5 mg/day)
Number of subjects: 160
Study 33660924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 32227128 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine invasive management strategy
Number of subjects: 8518
Study 32227128 — intervention group
Group type: COMPARATOR
Intervention: Conservative management strategy
Number of subjects: 8518
Study 32227128 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 8518
Study 32227128 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 8518
Study 616556944 — intervention group
Group type: EXPERIMENTAL
Intervention: Just-in-time training (JITT)
Number of subjects: 0
Study 616556944 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (TT)
Number of subjects: 0
Study 35690880 — intervention group
Group type: EXPERIMENTAL
Intervention: Index partner HIV self-test (HIVST)
Number of subjects: 180
Study 35690880 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 180
Study 33648572 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing 360-degree immersive virtual reality content played inside a head-mounted display with noise-cancelling headphones, three times a day
Number of subjects: 920
Study 33648572 — intervention group
Group type: COMPARATOR
Intervention: Standard ICU care
Number of subjects: 920
Study 35322393 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating insole device (VS) with 22-min daily vibrating sequences at 90% of tactile threshold
Number of subjects: 56
Study 35322393 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) using the same device but with noise set to 0
Number of subjects: 56
Study 35322393 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating insole device (VS)
Number of subjects: 56
Study 35322393 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 56
Study 33255731 — intervention group
Group type: EXPERIMENTAL
Intervention: FM containing Lactobacillus helveticus SBT2171 (LH2171)
Number of subjects: 200
Study 33255731 — intervention group
Group type: COMPARATOR
Intervention: Placebo FM
Number of subjects: 200
Study 616996904 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron (200 mg)
Number of subjects: 12
Study 616996904 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (160 mg)
Number of subjects: 12
Study 616996904 — intervention group
Group type: COMPARATOR
Intervention: Bisoprolol (10 mg)
Number of subjects: 12
Study 616996904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 34547750 — intervention group
Group type: EXPERIMENTAL
Intervention: New intelligibility test based on acoustic-phonetic decoding of pseudowords
Number of subjects: 117
Study 34547750 — intervention group
Group type: COMPARATOR
Intervention: Control group (39 healthy participants)
Number of subjects: 117
Study 33617797 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical length measurement
Number of subjects: 12407
Study 33617797 — intervention group
Group type: EXPERIMENTAL
Intervention: Funneling
Number of subjects: 12407
Study 33617797 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraamniotic debris
Number of subjects: 12407
Study 32240013 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (16 mmol nitrate/day)
Number of subjects: 16
Study 32240013 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted placebo
Number of subjects: 16
Study 35353651 — intervention group
Group type: EXPERIMENTAL
Intervention: PHBC (phospholipidic-curcumin complex)
Number of subjects: 0
Study 35353651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34363761 — intervention group
Group type: EXPERIMENTAL
Intervention: GARD (genomic-adjusted radiation dose)
Number of subjects: 1615
Study 34363761 — intervention group
Group type: COMPARATOR
Intervention: Physical dose of radiation
Number of subjects: 1615
Study 34363761 — intervention group
Group type: COMPARATOR
Intervention: Sham-GARD (standard-of-care dose without radiotherapy)
Number of subjects: 1615
Study 36135432 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip at 60% maximal voluntary contraction (IHG-60)
Number of subjects: 39
Study 36135432 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip at 30% maximal voluntary contraction (IHG-30)
Number of subjects: 39
Study 36135432 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 39
Study 33346349 — intervention group
Group type: EXPERIMENTAL
Intervention: Online communication training program
Number of subjects: 7
Study 33346349 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 7
Study 33371043 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month all-oral bedaquiline-containing regimen
Number of subjects: 0
Study 33371043 — intervention group
Group type: COMPARATOR
Intervention: 9-month injectable-containing regimen
Number of subjects: 0
Study 34847610 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu AG06466 (40 mg)
Number of subjects: 20
Study 34847610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 33663043 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated feedback during CPR
Number of subjects: 40
Study 33663043 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback withdrawal after initial feedback
Number of subjects: 40
Study 35370101 — intervention group
Group type: EXPERIMENTAL
Intervention: Penile prosthesis implantation with suspensory ligament release and pubic lipectomy via penopubic Z-plasty (group A)
Number of subjects: 61
Study 35370101 — intervention group
Group type: COMPARATOR
Intervention: Conventional penile prosthesis implantation via penoscrotal incision (group B)
Number of subjects: 61
Study 33375429 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant mix (bacopa, lycopene, astaxanthin, and vitamin B12)
Number of subjects: 80
Study 33375429 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 80
Study 36122965 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT
Number of subjects: 0
Study 36122965 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 0
Study 33631141 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol 37.5 mg/d
Number of subjects: 459
Study 33631141 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol 75 mg/d
Number of subjects: 459
Study 33631141 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol 150 mg/d
Number of subjects: 459
Study 33631141 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol 300 mg/d
Number of subjects: 459
Study 33631141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study 32725398 — intervention group
Group type: EXPERIMENTAL
Intervention: AR-HMD (augmented reality head-mounted display)
Number of subjects: 20
Study 32725398 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure without visual overlay
Number of subjects: 20
Study 32725398 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative study with AR-HMD
Number of subjects: 20
Study 36052011 — intervention group
Group type: EXPERIMENTAL
Intervention: AYURAKSHA kit (Sanshamani Vati, AYUSH Kadha, Anu Taila)
Number of subjects: 101
Study 36052011 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 101
Study 36052011 — intervention group
Group type: EXPERIMENTAL
Intervention: AYURAKSHA kit
Number of subjects: 101
Study 36052011 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study 35960174 — intervention group
Group type: COMPARATOR
Intervention: Standard technique/lidocaine injection
Number of subjects: 225
Study 35960174 — intervention group
Group type: EXPERIMENTAL
Intervention: New device/lidocaine patch
Number of subjects: 225
Study 35960174 — intervention group
Group type: EXPERIMENTAL
Intervention: New device/lidocaine injection
Number of subjects: 225
Study 33663566 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight Control of psoriatic arthritis (TICOPA) trial with a treat to target (T2T) strategy consisting of 4-weekly review and escalation of therapy (single DMARD, combination DMARDs, and then biologics) based on remission criteria.
Number of subjects: 0
Study 33663566 — intervention group
Group type: EXPERIMENTAL
Intervention: T2T approach within routine care in the MONITOR-PsA cohort.
Number of subjects: 0
Study 33663566 — intervention group
Group type: EXPERIMENTAL
Intervention: T2T approach supported when monitoring treatment within the cohort.
Number of subjects: 0
Study 32233189 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable polylactic acid membrane (PLA group)
Number of subjects: 20
Study 32233189 — intervention group
Group type: COMPARATOR
Intervention: Acellular dermal matrix membrane guided bone regeneration (ADMG group)
Number of subjects: 20
Study 34907431 — intervention group
Group type: EXPERIMENTAL
Intervention: INDI-FREEZE group (individualized protocol)
Number of subjects: 100
Study 34907431 — intervention group
Group type: COMPARATOR
Intervention: Control group (fixed protocol)
Number of subjects: 100
Study 32191657 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine 5mg before meals for one month
Number of subjects: 20
Study 32191657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34978231 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT) intervention for 10 sessions
Number of subjects: 30
Study 34978231 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 33468225 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MCI)
Number of subjects: 1000
Study 33468225 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1000
Study 33317579 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow nasal therapy (HFNT)
Number of subjects: 79
Study 33317579 — intervention group
Group type: COMPARATOR
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 79
Study 32596788 — intervention group
Group type: EXPERIMENTAL
Intervention: Second dose of ecological executive skills training (EEST)
Number of subjects: 70
Study 32596788 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group
Number of subjects: 70
Study 32035706 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV vaccination schedule (3+1) for HIV+ and HEU children; primary vaccination at 6/10/14 weeks and booster at 9-10 months.
Number of subjects: 484
Study 32035706 — intervention group
Group type: COMPARATOR
Intervention: HUU/3+1 (3-dose priming and booster), HUU/3+0 (3-dose priming without booster), HUU/2+1 (2-dose priming and booster).
Number of subjects: 484
Study 33484839 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenrolment permitted
Number of subjects: 219
Study 33484839 — intervention group
Group type: COMPARATOR
Intervention: Coenrolment not permitted
Number of subjects: 219
Study 34057299 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated weekly DCF (D 40 mg/m2, C 35 mg/m², F 1800 mg/m² over 24 h, on days 1 and 8 every 3 weeks)
Number of subjects: 106
Study 34057299 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortnightly DCF (D 50 mg/m2, C 50 mg/m², F 2000 mg/m² over 48 h every 2 weeks)
Number of subjects: 106
Study 36093809 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Action (PA) program
Number of subjects: 1200
Study 34154637 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention based on the Health Action Process Approach (HAPA) with immediate access after baseline assessment.
Number of subjects: 0
Study 34154637 — intervention group
Group type: COMPARATOR
Intervention: Control group with access to the web-based intervention only after follow-up assessment.
Number of subjects: 0
Study 32106344 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic mesh repair (mesh group, n=63)
Number of subjects: 122
Study 32106344 — intervention group
Group type: COMPARATOR
Intervention: Native tissue repair (native tissue group, n=59)
Number of subjects: 122
Study 32106344 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic mesh repair (mesh group)
Number of subjects: 122
Study 32106344 — intervention group
Group type: COMPARATOR
Intervention: Native tissue repair (native tissue group)
Number of subjects: 122
Study 35040014 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP training (6 weeks, 30 min meditation + 30 min aerobic exercise, once a week)
Number of subjects: 26
Study 35040014 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 26
Study 34739914 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (DMF) treatment
Number of subjects: 50
Study 34739914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 34875965 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio hypnotherapy for 15 minutes
Number of subjects: 64
Study 34875965 — intervention group
Group type: COMPARATOR
Intervention: Usual care (rest for about 15 minutes)
Number of subjects: 64
Study 33289663 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline (off label use)
Number of subjects: 0
Study 33289663 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline (for pneumonia)
Number of subjects: 0
Study 33289663 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline (various off label uses)
Number of subjects: 0
Study 34281921 — intervention group
Group type: EXPERIMENTAL
Intervention: SOFIA intervention (eHealth intervention including SOFIA-Monitoring and SOFIA-Coaching)
Number of subjects: 0
Study 34281921 — intervention group
Group type: COMPARATOR
Intervention: No-SOFIA (control group)
Number of subjects: 0
Study 35015210 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulipristal 10-mg daily
Number of subjects: 28
Study 35015210 — intervention group
Group type: COMPARATOR
Intervention: Combination oral contraceptive (COC)
Number of subjects: 28
Study 32931821 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week behavior change intervention aimed at increasing physical activity
Number of subjects: 51
Study 32931821 — intervention group
Group type: COMPARATOR
Intervention: usual care and disease-specific education (Control Group)
Number of subjects: 51
Study 32393216 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 945
Study 32393216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 945
Study 32393216 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Oriented Recovery Enhancement (MORE)
Number of subjects: 945
Study 35346380 — intervention group
Group type: EXPERIMENTAL
Intervention: MyComrade intervention delivered by pairs of general practitioners (GPs) in ROI, and a GP and practice-based pharmacist (PBP) in NI.
Number of subjects: 320
Study 35346380 — intervention group
Group type: COMPARATOR
Intervention: Usual care in control practices.
Number of subjects: 320
Study 34776826 — intervention group
Group type: EXPERIMENTAL
Intervention: diet + Sapere-method
Number of subjects: 144
Study 34776826 — intervention group
Group type: EXPERIMENTAL
Intervention: diet
Number of subjects: 144
Study 34776826 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 144
Study 35818198 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine and enalapril
Number of subjects: 110
Study 35818198 — intervention group
Group type: COMPARATOR
Intervention: Felodipine
Number of subjects: 110
Study 34127361 — intervention group
Group type: EXPERIMENTAL
Intervention: eComp
Number of subjects: 40
Study 34127361 — intervention group
Group type: COMPARATOR
Intervention: Standard tangential fields
Number of subjects: 40
Study 35106694 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐IUI and D‐IVF treatments in single women (SW)
Number of subjects: 251
Study 35106694 — intervention group
Group type: COMPARATOR
Intervention: D‐IUI and D‐IVF treatments in women in lesbian relationships (WLR)
Number of subjects: 251
Study 35106694 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐IUI treatments
Number of subjects: 251